Kimitoshi Kimura

Learn More
OBJECTIVE To compare effects of natalizumab on inflammatory and regulatory T cells with regard to expression of α4-integrin (CD49d). METHODS Twenty-seven natalizumab-naive and 8 natalizumab-treated patients with multiple sclerosis (MS), 7 patients with neuromyelitis optica (NMO) or NMO spectrum disorder, and 8 healthy controls were included. The positive(More)
  • 1